MedPath

Korea University Guro Hospital

🇰🇷South Korea
Ownership
Private
Employees
-
Market Cap
-
Website
http://guro.kumc.or.kr

Cardiac Stunning After Electrical Cardioversion

Active, not recruiting
Conditions
Atrial Fibrillation (AF)
First Posted Date
2024-12-31
Last Posted Date
2024-12-31
Lead Sponsor
Korea University Guro Hospital
Target Recruit Count
160
Registration Number
NCT06752733
Locations
🇰🇷

Korea University Medicine Guro hospital, Seoul, Korea, Republic of

Comparison of Therapeutic Effect Between Speech Rehabilitation Program and Speech Therapy in Stroke Patients With Aphasia

Not Applicable
Recruiting
Conditions
Stroke
Aphasia
Speech Therapy
Interventions
Procedure: Conventional language rehabilitation
Device: Zenicog;language rehabilitation program
First Posted Date
2024-04-12
Last Posted Date
2024-04-12
Lead Sponsor
Korea University Guro Hospital
Target Recruit Count
20
Registration Number
NCT06361901
Locations
🇰🇷

Department of Rehabilitation Medicine, Korea University Guro Hospital, Seoul, Korea, Republic of

SP Robotic Versus VATS Anatomical Pulmonary Resection for Patients With NSCLC

Not Applicable
Not yet recruiting
Conditions
Robotics
Lung Cancer
Interventions
Procedure: Single-port robotic-assisted thoracic surgery
Procedure: Single-port video-assisted thoracoscopic surgery
First Posted Date
2024-01-11
Last Posted Date
2024-01-11
Lead Sponsor
Korea University Guro Hospital
Target Recruit Count
290
Registration Number
NCT06202690

Concurrent OCT and FFR-guided PCI in CAD

Not Applicable
Recruiting
Conditions
Image
Coronary Artery Disease
Atheroscleroses, Coronary
Interventions
Diagnostic Test: optical coherence tomography and fractional flow reserve
Diagnostic Test: Coronary angiography
First Posted Date
2023-12-27
Last Posted Date
2023-12-27
Lead Sponsor
Korea University Guro Hospital
Target Recruit Count
700
Registration Number
NCT06182683
Locations
🇰🇷

Korea University Guro Hospital, Seoul, Korea, Republic of

Identification of Integrin ab Expression in Lung Cancer Patients

Completed
Conditions
Expression of Integrin ανβ3 in Lung Cancer
Interventions
Biological: Lung cancer types
First Posted Date
2023-12-13
Last Posted Date
2023-12-13
Lead Sponsor
Korea University Guro Hospital
Target Recruit Count
61
Registration Number
NCT06167941
Locations
🇰🇷

Department of Thoracic and Cardiovascular Surgery, Korea University Guro Hospital, Seoul, Korea, Republic of

Neratinib and Trastuzumab Biosimilar in Patients With HER2 Mutated Advanced Solid Cancers

Phase 2
Active, not recruiting
Conditions
Metastatic Cancer
HER2 Gene Mutation
Interventions
First Posted Date
2023-10-16
Last Posted Date
2024-03-13
Lead Sponsor
Korea University Guro Hospital
Target Recruit Count
42
Registration Number
NCT06083662
Locations
🇰🇷

Korea university Guro hospital, Seoul, Korea, Republic of

The Effect of Extracorporeal Shock Wave Therapy After Botulinum Toxin Type A Injection for Post-stroke Spasticity

Not Applicable
Completed
Conditions
Muscle Spasticity
Stroke
Hemiplegia, Spastic
Interventions
Device: Extracorporeal shock wave therapy
Procedure: Botulinum toxin treatment
First Posted Date
2023-06-05
Last Posted Date
2023-06-05
Lead Sponsor
Korea University Guro Hospital
Target Recruit Count
16
Registration Number
NCT05889026
Locations
🇰🇷

Korea university guro hospital, Seoul, Korea, Republic of

Impact of CES1 Genotype on Remimazolam

Recruiting
Conditions
Adult
Middle Aged
Elective Surgical Procedures
Interventions
First Posted Date
2023-05-03
Last Posted Date
2024-10-14
Lead Sponsor
Korea University Guro Hospital
Target Recruit Count
120
Registration Number
NCT05841667
Locations
🇰🇷

Korea University Guro Hospital, Seoul, Korea, Republic of

Impact of Maxigesic on Delirium After Minimally Invasive Lung Surgery in Elderly Patients

Phase 4
Recruiting
Conditions
Lung Neoplasms
Robotic Surgical Procedures
Thoracic Surgery, Video-Assisted
Delirium
Aged
Interventions
First Posted Date
2023-04-28
Last Posted Date
2023-09-06
Lead Sponsor
Korea University Guro Hospital
Target Recruit Count
176
Registration Number
NCT05834569
Locations
🇰🇷

Korea University Guro Hospital, Seoul, Korea, Republic of

Comparison of Clinical Efficacy Between Letrozole + Ribociclib and Fulvestrant + Letrozole + Ribociclib in Hormone Receptor Positive, HER2 Negative Metastatic Breast Cancer

Phase 2
Recruiting
Conditions
Metastatic Breast Cancer
Interventions
First Posted Date
2023-04-18
Last Posted Date
2023-10-06
Lead Sponsor
Korea University Guro Hospital
Target Recruit Count
202
Registration Number
NCT05816655
Locations
🇰🇷

St Mary Hospital, Seoul, Korea, Republic of

🇰🇷

Korea university Guro hospital, Seoul, Korea, Republic of

© Copyright 2025. All Rights Reserved by MedPath